Signal cleavage sites of equine herpesvirus 1 (EHV-1) glycoproteins D and B (gD and gB) and an endoproteolytic cleavage site of EHV-1 gB were determined by N-terminal amino acid sequencing and compared with known cleavage sites of homologues in other herpesviruses. Signal cleavage of EHV-1 gD occurred between Arg 35 and Ala 36 in a region of basic amino acids resembling the endoproteolytic cleavage sites of viral glycoproteins, nine amino acids downstream of the predicted site, while EHV-1 gB was cleaved as predicted between Ala s5 and Val s~. Endoproteolytic cleavage of EHV-1 gB occurred between Arg 54s and Ala 5aa, 28 amino acids downstream of the cleavage site predicted from conserved sequences of other herpesvirus gB homologues. One interpretation of these data is that EHV-1 gB is cleaved internally at both sites, a possibility which was supported by the apparent molecular masses of the unglycosylated gB subunits produced in the presence of tunicamycin. This double cleavage would release a stretch of amino acids which is not present in sequenced gB molecules of other herpesviruses. Experiments with glycosylation inhibitors indicated that cleavage of EHV-1 gB can occur in the absence of glycosylation. N-terminal sequencing also determined that a 42 kDa EHV-1 glycoprotein was a product of internal cleavage of the protein encoded by gene 71. Staggered endoproteolytic cleavage after adjacent arginine residues 506 and 507 separates the 42 kDa Cterminal subunit containing all the cysteine residues from the serine and threonine rich N-terminal region.
Introduction
Envelope glycoproteins of herpesviruses play essential roles in the infectious process, viral pathogenesis and interaction with the host immune system (Spear, 1985; Blacklaws & Nash, 1990; Manservigi & Cassai, 1991) . The primary translation products of many herpesvirus glycoproteins, like other viral glycoproteins, share features characteristic of class 1 membrane proteins (Wiley, 1985) . A short hydrophobic signal sequence (McGeoch, 1985; Perlman & Halvorsen, 1983) at the N terminus of the newly synthesized polypeptide marks it for translocation into the lumen of the endoplasmic reticulum (ER), and a C-terminal hydrophobic sequence acts as a transmembrane anchor (Spear, 1985) . In the ER the signal sequence is enzymatically cleaved from the protein at a specific site by a signal peptidase and the newly synthesized protein is modified by folding, formation of disulphide bonds and addition of high-mannose asparagine-linked (N-linked) oligosaccharides (Doms et al., * Author for correspondence. Fax +61 2 850 8245. e-mail mwhalley@rna.bio.mq.edu.au 1993; Kornfeld & Kornfeld, 1985) . N-terminal amino acid sequencing has been used to determine the signal cleavage sites of a number of herpesvirus glycoproteins, such as the glycoprotein D (gD) homologues of herpes simplex viruses 1 and 2 (HSV-1 and HSV-2) (Eisenberg et al., 1984) and bovine herpesvirus 1 (BHV-1) (Tikoo et al., 1990) , and the glycoprotein B (gB) homologues of HSV-1 (Pachl et al., 1987; Claesson-Welsh & Spear, 1987) , varicella-zoster virus (VZV) (Keller et al., 1986) and pseudorabies virus (PRV) (W61fer et al., 1990) .
Endoproteolytic cleavage and oligomer formation are also involved in conformational maturation of herpesvirus gB molecules (Pereira, 1994) . The gB homologues of most herpesviruses including equine herpesvirus 1 (EHV-1), EHV-4, PRV, VZV, BHV-1, feline herpesvirus 1, Marek's disease virus and human cytomegalovirus (HCMV) undergo proteolytic cleavage by a cellular protease, generating disulphide-linked products. The PRV gB homologue (gII) is cleaved after complex sugar modifications in the Golgi (Whealy et al., 1990) , and HCMV gB is cleaved by a cellular protease in a post-ER compartment after complete glycosylation (Britt & Vugler, 1989; Spaete et al., 1990) The proteolytic cleavage sites of the gB homologues of PRV, VZV and 0001-3493 © 1996 SGM HCMV (Towne) (Keller et al., 1986; Spaete et al., 1988; W61fer et al., 1990) , determined by N-terminal amino acid sequencing of the purified subunit, occur at a basic sequence motif Arg-X-Lys/Arg-Arg-Ser which is conserved in cleaved gB homologues, but not in the uncleaved gB products of HSV and Epstein-Barr virus.
A number of class 1 membrane glycoproteins are encoded by the EHV-1 genome (Allen & Yeargan, 1987; Telford et al., 1992) and most, including gB and gD, have identifiable homologues in other herpesviruses. One exception is gene 71 (Telford et al., 1992) which has no known homologue in any of the herpesviruses sequenced to date, apart from the closely related EHV-4 (Nagesha et al., 1993) . The signal cleavage sites of EHV-1 gD (Flowers et al., 1991; Audonnet et al., 1990; Whalley et al., 1991) and EHV-1 gB (Whalley et al., 1989) were predicted from deduced amino acid sequences using the (-3,-1) rule of von Heijne (1984) although these have not been verified by direct amino acid sequencing. EHV-1 gB is cleaved to yield subunits of approximately 76 and 54 kDa which are linked by disulphide bonds to form a 145 kDa heterodimer (Sullivan et al., 1989; Meredith et al., 1989) . Endoproteolytic cleavage of EHV-1 gB was expected to occur at the same basic site as the gB homologues of VZV, PRV and HCMV. Here we have used N-terminal sequencing to define the signal cleavage sites of EHV-1 gB and gD and the endoproteolytic cleavage site of EHV-1 gB, and to demonstrate that the translation product of EHV-1 gene 71 (Telford et al., 1992; ) also undergoes internal proteolytic cleavage. The effect of glycosylation on cleavage of EHV-1 gB was also investigated.
Methods
Virus' and cell culture. EHV-1 (isolate HVS 25A) (Whalley et al., 1981) was propagated in rabbit kidney (RK13) cells in Dulbecco's modified Eagle's medium supplemented with 2 % fetal bovine serum (CSL Ltd).
Monoclonal antibodies (MAbs) and antisera. MAbs 1F12 (anti-gD), 7BI0 (anti-gB large subunit) and 8B6 (anti-gene 71 product) were generated against EHV-1 HVS 25A (Wellington et al., 1995) . These antibodies were purified for affinity chromatography from ascitic fluid by the Affi-Gel Protein A MAPS II method (Bio-Rad). MAbs 3F6 (anti gB large subunit) and 12D12 (anti-gB small subunit) were kindly supplied by G.P. Allen, University of Kentucky, USA (Allen & Yeargan, 1987) . Rat anti-EHV-1 gD polyclonal antiserum was prepared against an E. coli fusion product of EHV-1 gD (Love et al., 1992) .
Western blotting. EHV-1 infected RK 13 cell proteins were solubilized by boiling for 3 min in buffer containing 50 mM-Tris-HC1 (pH 6.8), 2 % SDS, 10% glycerol and 100mM-dithiothreitol (DTT) and electrophoresed using the Laemmli buffer system in mini gels of 8% or 10% acrylamide, cross-linked with 2.6% N,N'-bis-methylene acrylarnide (Laemmli, 1970) . Proteins were transferred electrophoretically onto nitrocellulose using a semi-dry method (Kyhse-Andersen, 1984 ) and then probed with MAbs or monospecific antiserum to EHV-1 glycoproteins.
Extraction of envelope glycoproteins from EHV-1 infected cells. All procedures were performed at 4 °C. EHV-1 infected cells and cellreleased virus were harvested by centrifugation for 1 h at 80000 g. After washing the pellet once in phosphate-buffered saline (PBS) and recentrifugiug, it was resuspended in a minimum volume of extraction buffer containing 50 mM-Tris pH 75, 1% Triton X-100, 0-15 M-NaC1, 10mM-EDTA, and the protease inhibitors phenylmethylsulphonyl fluoride (PMSF) (0.3 mM) and leupeptin (4 gM). Due to instability of PMSF, it was replenished at intervals during the subsequent procedures. After standing for 1 h with intermittent mixing, the suspension was centrifuged for 1 h at 100 000 g. The supernatant, which contained the EHV-1 envelope glycoproteins, was stored frozen and was recentrifuged on thawing at 2500 g for 15 min at 4 °C.
Immunoaffinity chromatography. EHV-I gD, gB and 8B6 antigen were purified from the detergent extract supernatant fluid by immunoaffinity chromatography with purified MAbs (1F12, 7B10 and 8B6 respectively) coupled to CNBr-activated Sepharose 4B (Sigma) essentially according to the manufacturer's instructions. Bound antigen was eluted from the column with 50mM-diethylamine pH 11.5 containing 0-05 % Triton X-100. Antigen-containing fractions, which were identified by a dot immunobinding assay, were pooled, dialysed against PBS containing 0.05% Triton X-100 and concentrated in a Centricon-10 (gD) or Centricon-30 (gB and 8B6 antigen) centrifugal concentrator (Amicon).
N-terminal amino acid sequencing.
Purified glycoproteins were mixed with electrophoresis sample buffer containing 100 mM-DTT, incubated at 37 °C for 6 rain, electrophoresed as described for Western blotting and transferred electrophoretically to polyvinylidene difluoride (PVDF) membrane (Bio-Rad) using a buffer containing 10 raM-CAPS, 10 % methanol pH 11.0. Protein was detected on the PVDF membrane with 0.1% amido black in 1% acetic acid and 40 % methanol, while a reference strip was stained by immunoblotting to verify the location of the required glycoprotein band. The bands used for sequencing are shown in Fig. 1 . The amido black-stained glycoprotein band was cut out of the PVDF membrane and subjected to N-terminal sequencing by Edman degradation on a Porton Instruments PI2090 equipped with a Beckman System Gold micro PTH (phenylthiohydantoin) amino acid analyser.
Effect of glyeosylation inhibitors. Monolayers of RKI3 cells were
infected with EHV-1 at 5 p.f.u./cell. After adsorption for 2 h at 4 °C, either 1 lag/ml tunicamycin (Sigma), 1 pM-monensin (Sigma) or no inhibitor was added in medium containing 2% FBS. Incubation was continued at 37 °C until cytopathic effect was > 90% (18 h), and the cultures were harvested at 80000 g for 1 h at 4 °C. Infected-cell extracts were electrophoresed under reducing conditions and the gB molecules were compared on Western blots probed with MAbs 3F6 (anti-large subunit) and 12D12 (anti-small subunit).
Results and Discussion
Identification of purified glyeoproteins Fig. 1 shows the identification by immunoblotting of purified EHV-1 glycoproteins. The identities of the gD products purified with MAb 1F 12 were verified by antigD polyclonal antiserum (Fig. 1 a) . In addition to the upper bands of the gD monomer (approx. 54 kDa) used for N-terminal sequencing, MAb 1F12 purified a high molecular mass form ( > 200 kDa) which may be either a homooligomer of gD or a heterooligomer involving other EHV-1 proteins. Fig. l(b, c) shows the large (64-80 kDa) and small subunits (55 kDa) of gB respectively, after DTT reduction of the disulphide-linked dimer obtained on purification with MAb 7B10 (anti-gB large subunit). The identities of these subunits were confirmed by probing blots with MAbs 3F6 (anti-large subunit) and 12D12 (anti-small subunit). Fig. 1 (d) shows that MAb 8B6 purified a major protein with an apparent molecular mass of 42 kDa, a high molecular mass protein of > 250 kDa and a third minor protein with an approximate molecular mass of I00 kDa.
Signal cleavage sites of EHV-1 gD and gB
Data obtained from N-terminal sequencing of gD and the large subunit of gB are shown in Fig. 2 (a) . The signal cleavage site was determined by alignment of each N terminus with the amino acid sequence predicted from translation of the nucleotide sequence. The locations of the cleavage sites on the complete translation products are shown schematically for each glycoprotein in Fig.  2(b) . The signal cleavage site for EHV-1 gB was between Ala sS and Va186 as predicted, while for EHV-1 gD the cleavage site was between Arg 35 and Ala 36, nine amino acids downstream of the predicted site (Whalley et al., 1991; Flowers et al., 1991) . An identical N-terminal sequence was obtained for purified EHV-1 gD expressed by a Chinese hamster ovary (CHO) cell line (J. E. Wellington, unpublished results). Fig. 3 , which compares the signal cleavage sites of EHV-1 gD and gB with known cleavage sites of the gD and gB homologues in other herpesviruses, shows that each of the cleavage sites, with the exception of EHV-1 gD, agrees with consensus recognition patterns for signal peptidase and with the ( -3, -1) rule derived from the analysis of eukaryotic and prokaryotic signal sequences (von Heijne, 1984; Perlman & Halvorsen, 1983) . Although the experimentally determined cleavage site of EHV-1 gD with arginine in position -1 is unusual, alanine in positions -3 and + 1, and charged residues (e.g. arginine) at -2 , + 3 and + 5 are common occurrences in the analysed signal sequences. It is possible, however, that signal cleavage in fact occurs at the predicted site close to the hydrophobic core, while endoproteolytic cleavage occurs at the observed N terminus, since the sequence motif at this site resembles the basic tetrapeptide Arg/Lys-X-Arg/LysArg recognized by cellular proteases (McCune et at., 1988; Perez & Hunter, 1987) .
Endoproteolytic cleavage of EHV-1 gB
The N-terminal sequence determined for two separate bands of the small subunit of gB established that internal cleavage of gB occurred between Arg 54s and Ala 549 (Fig.  2) . It can be seen from comparison of amino acids at the known cleavage sites of the gB homologues of EHV-1, PRV, VZV and HCMV (Fig. 3) that cleavage of EHV-1 gB did not occur at the expected conserved Arg-XLys/Arg-Arg-Ser sequence, but at an alternative basic sequence Arg-Leu-His-Lys-Arg, 28 amino acids down- 
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N-terminal sequences
Predicted from gene sequence Residue no. . Amino acid sequences of N termini of processed EHV-I gD, small and large subunits of EHV-I gB, and the 42 kDa cleavage product of gene 7 I, aligned with amino acid sequences predicted from nucleotide sequences (Whalley et al., 1989 (Whalley et al., , 1991 Telford et al., 1992) . V, Cleavage sites. Q above the gD sequence represents the observation of a significant amount of glutamine at +4 from the cleavage site. (b) Schematic diagram representing translation products of the EHV-1 genes for gD and gB and EHV-1 gene 71 (Whalley et al., 1989 (Whalley et al., , 1991 Telford et al., 1992) showing cleavage sites (V), predicted cleavage sites (V), cysteine residues (C), potential N-linked glycosylation sites (lollipops) and hydrophobic regions (IN).
stream of the predicted site in a region of amino acids unique to the gB homologue of EHV-1. Thus the predicted unmodified molecular masses of the large and (Eisenberg et al., 1984; Whalley et al., 1989 Whalley et al., , 1991 Keller et al., 1986; Spaete et aI., 1988 ; W61fer et al., 1990; ClaessonWelsh & Spear, 1987; Tikoo et al., 1990; Telford et al., 1992) . * VZV numbering based on initiating methionine at residue -63 relative to predicted start site of Davison & Scott (1986) . V, Cleavage sites; V, predicted cleavage sites. Hydrophobic regions (underlined) were derived using the ALOM package of the Australian National Genome Information Service (ANGIS), based on the parameters of Kyte & Doolittle (1982) .
a cellular protease after a basic tetrapeptide which generally follows the pattern Arg-X-Arg/Lys-Arg (Perez & Hunter, 1987; McCune et al., 1988) , or a sequence of four or more basic residues as in Rous sarcoma virus glycoprotein and avian influenza virus haemagglutinin (Perez & Hunter, 1987; Walker & Kawaoka, 1993) . Thus the predicted cleavage site for EHV-1 gB (Whalley et al., 1989) appears to be a strong recognition sequence (ArgArg-Arg-Arg). It is possible that gB is cleaved at both the predicted site and the observed site, in which case the 28 amino acids between the two sites would be missing from the C terminus of the large subunit. This would result in a large subunit with an unmodified molecular mass of 50 kDa, close to that of the small subunit (48 kDa). The results of the tunicamycin experiment described in the following section were consistent with cleavage at both sites. It is interesting that this double cleavage would remove a stretch of amino acids which is not present in other sequenced gB homologues (Whalley et al., 1989) and may have been discarded by other herpesviruses or acquired independently by EHV-1.
Effect of glycosylation on cleavage of EHV-1 gB
Glycosylation inhibitors such as tunicamycin and monensin have provided useful tools for studying the processing of N-linked and O-linked oligosaccharides of herpesvirus glycoproteins (Spear, 1985) . The antibiotic tunicamycin partially or completely blocks the glycosylation of glycoproteins by inhibiting the addition of highmannose N-linked oligosaccharides in the ER (Doms et al., 1993; Campadelli-Fiume & Serafini-Cessi, 1985) , while the ionophore monensin, which interferes with Golgi function, blocks both the processing of N-linked oligosaccharides and the addition of O-linked oligosaccharides to HSV-1 glycoproteins (Johnson & Spear, 1983; Spear, 1985) . Fig. 4 shows an analysis of EHV-1 gB forms in extracts of EHV-1 infected RK 13 cells propagated in the presence or absence of tunicamycin or monensin. In the absence ofinhibitors, the 137 kDa glycosylated precursor (Sullivan et al., 1989) was recognized by both 3F6 and 12D12, while the large and small subunits had apparent molecular masses of 64-80 kDa and 55 kDa respectively. Additional lower molecular mass bands, particularly for the large subunit, which were detected in this experiment due to the large amount of antigen loaded, may represent various stages of processing or degradation of EHV-1 gB. In the presence of monensin, the molecular masses of the glycosylated precursor and small subunit did not change, suggesting a lack of processing of these molecules in the Golgi, while the large subunit was modified to 67-71 kDa.
In the presence of tunicamycin the glycosylated precursor was replaced with a band of 106 kDa which corresponds to the unglycosylated translation product, designated l l 8 k D a by Sullivan et al. (1989) , and calculated as 101 kDa from the amino acid sequence after removal of the signal sequence (Whalley et al., 1989) . Tunicamycin reduced both subunits to molecular masses of 49 kDa, the approximate predicted molecular masses of the cleaved unglycosylated translation products if cleavage occurred at both the predicted and observed sites. If cleavage had occurred at only the observed site then the unglycosylated molecular mass of the large subunit would be 5 kDa greater than the small subunit.
These results indicated that EHV-1 gB could be cleaved in the unglycosylated form. The range of molecular masses of the large subunit in the absence of glycosylation inhibitors also suggested that either the precursor was cleaved at various stages of processing or the large subunit underwent carbohydrate modifications after cleavage. This is in contrast to the gB homologues of HCMV and PRV in which cleavage appears to occur in the Golgi after complex sugar modifications (Britt & Vugler, 1989; Whealy et al., 1990; Spaete et al., 1990) . Britt & Vugler (1989) found that HCMV gB was not cleaved in the presence of monensin, while Spaete et al. (1990) showed that HCMV gB expressed in CHO cells was not cleaved when transport from the ER to the Golgi was blocked with the ionophore carbonyl cyanide m-chlorophenylhydrazone. It is possible that although cleavage of EHV-1 gB can occur in the ER in the absence of glycosylation, it may occur more efficiently in the Golgi, but before complex sugar modifications are complete.
The significance of cleavage of most gB homologues in replication and pathogenicity is uncertain. In contrast to many other viral proteins involved in membrane fusion (White, 1990; Spear, 1987) , failure to cleave gB homologues has no effect on their function in penetration or cell-cell fusion (Blewett & Misra, 1991; Pereira, 1994) , although spread of infection from cell to cell can be retarded (Kopp et al., 1994) . However, oligomerization of the gB homologues may play a role in the infectious process since the formation ofhomodimers ofHSV-1 gB, which is not cleaved, appears to be required for infectivity of HSV-1 (Pereira, 1994) .
Identification and cleavage of the translation product of gene 71
The 42 kDa protein recognized by MAb 8B6 was present both in EHV-1 infected cells (Fig. l d) and as the predominant form in extracellular virus (not shown). A decrease in molecular mass of 1 2 kDa on removal of Nlinked sugars with N-glycosidase F (Boehringer Mannheim) showed that this 42 kDa antigen was a glycoprotein, but it was not readily identified as one of the previously characterized glycoproteins of EHV-1. Nterminal sequencing and comparison of the sequence with the predicted sequences of EHV-1 proteins (Telford et al., 1992) revealed 100% identity with an internal region of the translation product of gene 71 (Fig. 2) . The data, which showed two N-terminal sequences, indicated that staggered processing of the gene 71 product occurred after adjacent arginine residues 506 and 507, following the basic sequence Arg-His-His-Arg-Gly-Arg-Ala-GlyGly-Arg-Arg. The highly basic nature of this sequence immediately upstream of the cleavage site compares with the basic sequence motifs upstream of the endoproteolytic cleavage sites of the gB homologues (Fig. 3) . However, like the observed cleavage site for EHV-1 gB, the adjacent cleavage sites for the gene 71 product do not occur after the common tetrapeptide recognition sequence Arg-X-Arg/Lys-Arg. It is possible that such cleavage events involve different proteases.
EHV-1 gene 71 (Telford et al., 1992) , which is located in the short unique region of the genome immediately upstream of the gD gene, is not essential for replication in cell culture . It encodes a predicted polypeptide of 80 kDa which may be represented by the minor band in Fig. 1 (d) . Data indicate that the gene 71 product is processed with both N-linked and O-linked carbohydrates to yield a glycoprotein with an apparent molecular mass of 192 kDa . The high molecular protein recognized by MAb 8B6 (> 250 kDa) was shown by analysis of amino acid composition to correspond closely to the predicted product of gene 71 (K. Ou, personal communication). The apparent discrepancy between the reported sizes of the high molecular mass gene 71 product could be due either to strain variation or to the effects of high levels of glycosylation on electrophoretic mobility. The experimentally determined adjacent cleavage sites of the gene 71 product divide the molecule into a serine and threonine rich N-terminal subunit with no cysteine residues after removal of the signal sequence, and a Cterminal subunit (8B6 antigen) with 12 cysteine residues and a single potential N-linked glycosylation site (Fig.  2b) . The occurrence of glycosylation at this site was supported by the observed decrease of 1-2 kDa in the 42 kDa molecular mass of this subunit following treatment with N-glycosidase F. Since the predicted molecular mass of the unmodified C-terminal subunit is 32 kDa, it is likely that there is also some O-linked glycosylation. However, the high level of O-linked glycosylation on the uncleaved product must occur mainly on the serine and threonine rich N-terminal region. Unlike EHV-1 gB, the formation of a disulphide-linked heterodimer of the subunits of the gene 71 product would not be possible due to the lack of cysteine residues on the N-terminal subunit. There was no evidence for oligomerization of the 42 kDa C-terminal subunit since MAb 8B6 recognized the same band of 42 kDa after electrophoresis of EHV-1 infected cell proteins under non-reducing conditions (not shown). The role of the EHV-1 gene 71 product in the infectious process is not yet known, but endoproteolytic cleavage may be important in providing two subunits with quite different structure and properties.
The analysis of cleavage sites described here provides insight into the specific processing events involved in the maturation of three glycoproteins of EHV-1. In addition to defining domains of possible functional significance, knowledge of the N-terminal sequences of the mature products is also relevant for the design and construction of expression systems for EHV-1 glycoproteins.
